🔎 Trials Near Me

Home › Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance clinical trials recruiting in the U.S.

12 studies for Monoclonal Gammopathy of Undetermined Significance are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 13, 2026 · NCT06644625

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT02269592

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT02726750

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT05136807

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT05361694

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 23, 2026 · NCT01408225

The Indiana Myeloma Registry

RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT03616483

Sleep Apnea in Patients With MGUS and MM

RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Nov 10, 2025 · NCT04114084

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.